Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hatsumi Yoshiki is active.

Publication


Featured researches published by Hatsumi Yoshiki.


British Journal of Pharmacology | 2012

Regional quantification of muscarinic acetylcholine receptors and β‐adrenoceptors in human airways

T Ikeda; Asm Anisuzzaman; Hatsumi Yoshiki; M Sasaki; T Koshiji; Junsuke Uwada; Atsushi Nishimune; Hiroshi Itoh; Ikunobu Muramatsu

BACKGROUND AND PURPOSE Muscarinic acetylcholine receptors (mAChRs) and β‐adrenoceptors in the airways and lungs are clinically important in chronic obstructive pulmonary disease (COPD) and asthma. However, the quantitative and qualitative estimation of these receptors by radioligand binding approaches in human airways has not yet been reported because of tissue limitations.


British Journal of Pharmacology | 2008

Identification of the α1L-adrenoceptor in rat cerebral cortex and possible relationship between α1L- and α1A-adrenoceptors

Shigeru Morishima; Fumiko Suzuki; Hatsumi Yoshiki; A S Md Anisuzzaman; Zakia Sultana Sathi; Takashi Tanaka; Ikunobu Muramatsu

In addition to α1A, α1B and α1D‐adrenoceptors (ARs), putative α1L‐ARs with a low affinity for prazosin have been proposed. The purpose of the present study was to identify the α1A‐AR and clarify its pharmacological profile using a radioligand binding assay.


Journal of Neurochemistry | 2013

Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus.

Abu Syed Md Anisuzzaman; Junsuke Uwada; Takayoshi Masuoka; Hatsumi Yoshiki; Matomo Nishio; Yuji Ikegaya; Naoya Takahashi; Norio Matsuki; Yasuhisa Fujibayashi; Yoshiharu Yonekura; Toshihiko Momiyama; Ikunobu Muramatsu

Muscarinic acetylcholine receptors (mAChRs) are well known to transmit extracellular cholinergic signals into the cytoplasm from their position on the cell surface. However, we show here that M1‐mAChRs are also highly expressed on intracellular membranes in neurons of the telencephalon and activate signaling cascades distinct from those of cell surface receptors, contributing uniquely to synaptic plasticity. Radioligand‐binding experiments with cell‐permeable and ‐impermeable ligands and immunohistochemical observations revealed intracellular and surface distributions of M1‐mAChRs in the hippocampus and cortex of rats, mice, and humans, in contrast to the selective occurrence on the cell surface in other tissues. All intracellular muscarinic‐binding sites were abolished in M1‐mAChR‐gene‐knockout mice. Activation of cell surface M1‐mAChRs in rat hippocampal neurons evoked phosphatidylinositol hydrolysis and network oscillations at theta rhythm, and transiently enhanced long‐term potentiation. On the other hand, activation of intracellular M1‐mAChRs phosphorylated extracellular‐regulated kinase 1/2 and gradually enhanced long‐term potentiation. Our data thus demonstrate that M1‐mAChRs function at both surface and intracellular sites in telencephalon neurons including the hippocampus, suggesting a new mode of cholinergic transmission in the central nervous system.


The Journal of Urology | 2010

Visualization and Tissue Distribution of α1L-Adrenoceptor in Human Prostate by the Fluorescently Labeled Ligand Alexa-488-Silodosin

Shigeru Morishima; Fumiko Suzuki; Atsushi Nishimune; Hatsumi Yoshiki; Hironobu Akino; Osamu Yokoyama; Ikunobu Muramatsu

PURPOSE Although alpha(1L)-adrenoceptor is recognized as a target of alpha(1) antagonist therapy for benign prostatic hyperplasia, the most common techniques, such as immunohistochemistry and in situ hybridization, are not applicable to examine alpha(1L)-AR vs alpha(1A)-AR tissue distribution because alpha(1L)-AR is now considered another phenotype sharing the alpha(1A)-AR gene and protein molecule. We labeled the alpha(1A) and alpha(1L)-adrenoceptor selective antagonist silodosin (Kissei Pharmaceutical, Matsumoto, Japan) with the fluorophore Alexa Fluor(R) 488 (Alexa-488-silodosin) to visualize alpha(1L)-AR expression. MATERIALS AND METHODS Radioligand binding and functional bioassay experiments were done to assess alpha(1)-AR expression in Chinese hamster ovary cells and human prostate tissues. Confocal imaging was subsequently performed. RESULTS Although Alexa-488-silodosin had about 10 times lower affinity for all alpha(1)-AR subtypes than silodosin in binding and functional studies, it had high selectivity to alpha(1A) and alpha(1L)-ARs. Confocal imaging revealed clear localization of fluorescence on the membrane of Chinese hamster ovary cells expressing alpha(1A)-AR but not alpha(1B)-and alpha(1D)-ARs, and in the muscle layer of the human prostate. The fluorescent signal in Chinese hamster ovary cells disappeared in the presence of 3 nM prazosin but fluorescence was observed in the human prostate even in the presence of 100 nM prazosin. CONCLUSIONS Alexa-488-silodosin is a powerful fluorescent probe with high selectivity to alpha(1A) and alpha(1L)-ARs. Thus, Alexa-488-silodosin successfully visualizes the site of alpha(1L)-ARs in the muscle layer of the human prostate without losing its distinct pharmacological profile.


British Journal of Pharmacology | 2008

Native profiles of α1A‐adrenoceptor phenotypes in rabbit prostate

T.-H. Su; Shigeru Morishima; Fumiko Suzuki; Hatsumi Yoshiki; Asm Anisuzzaman; Takashi Tanaka; Juei-Tang Cheng; Ikunobu Muramatsu

α1‐Adrenoceptors in the rabbit prostate have been studied because of their controversial pharmacological profiles in functional and radioligand binding studies. The purpose of the present study is to determine the native profiles of α1‐adrenoceptor phenotypes and to clarify their relationship.


Journal of Biological Chemistry | 2014

Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells.

Yukihiro Kimura; Kazuyasu Chihara; Chisato Honjoh; Kenji Takeuchi; Shota Yamauchi; Hatsumi Yoshiki; Shigeharu Fujieda; Kiyonao Sada

Background: β-Glucan receptor Dectin-1 in dendritic cells and macrophages plays important roles in antifungal immunity. Results: Dectin-1 is expressed in rat mast cells, and its tyrosine phosphorylation induces characteristic gene expression of transcription factors and cytokines through protein-tyrosine kinase Syk. Conclusion: Dectin-1 functions in rat mast cells. Significance: Dectin-1-mediated signaling in mast cells may contribute to antifungal immunity. Dectin-1 recognizes β-glucan and plays important roles for the antifungal immunity through the activation of spleen tyrosine kinase (Syk) in dendritic cells or macrophages. Recently, expression of Dectin-1 was also identified in human and mouse mast cells, although its physiological roles were largely unknown. In this report, rat mast cell line RBL-2H3 was analyzed to investigate the molecular mechanism of Dectin-1-mediated activation and responses of mast cells. Treatment of cells with Dectin-1-specific agonist curdlan induced tyrosine phosphorylation of cellular proteins and the interaction of Dectin-1 with the Src homology 2 domain of Syk. These responses depended on tyrosine phosphorylation of the hemi-immunoreceptor tyrosine-based activation motif in the cytoplasmic tail of Dectin-1, whereas they were independent of the γ-subunit of high-affinity IgE receptor. DNA microarray and real-time PCR analyses showed that Dectin-1-mediated signaling stimulated gene expression of transcription factor Nfkbiz and inflammatory cytokines, such as monocyte chemoattractant protein-1, IL-3, IL-4, IL-13, and tumor necrosis factor (TNF)-α. The response was abrogated by pretreatment with Syk inhibitor R406. These results suggest that Syk is critical for Dectin-1-mediated activation of mast cells, although the signaling differs from that triggered by FcϵRI activation. In addition, these gene expressions induced by curdlan stimulation were specifically observed in mast cells, suggesting that Dectin-1-mediated signaling of mast cells offers new insight into the antifungal immunity.


Journal of Neurochemistry | 2011

Intracellular distribution of functional M1‐muscarinic acetylcholine receptors in N1E‐115 neuroblastoma cells

Junsuke Uwada; Abu Syed Md Anisuzzaman; Atsushi Nishimune; Hatsumi Yoshiki; Ikunobu Muramatsu

J. Neurochem. (2011) 118, 958–967.


European Journal of Pharmacology | 2008

Different affinities of native α1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations

Zakia Sultana Sathi; Abu Syed Md Anisuzzaman; Shigeru Morishima; Fumiko Suzuki; Takashi Tanaka; Hatsumi Yoshiki; Ikunobu Muramatsu

The pharmacological profiles of alpha1-adrenoceptors for ketanserin, prazosin, silodosin, and BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4,5]decane-7,9-dione dihydrochloride) were examined under different assay conditions. Among the tested antagonists and alpha1-adrenoceptors subtypes, ketanserin showed significantly lower affinity for the alpha1B-adrenoceptor subtype in intact tissue sampled from the rat tail artery, thoracic aorta, and cerebral cortex (functional pKB and binding pKi were approximately 6), than in cerebral cortex membrane preparations or whole cell and membrane preparations of alpha1B-adrenoceptor transfected human embryonic kidney 293T (HEK 293T) cells (pKi was approximately 8). In these tissues and cells, however, ketanserin showed a similar affinity (pKi = approximately 8) for alpha1A- and alpha1D-adrenoceptors even though the assays were conducted under different conditions. In contrast, the affinities of alpha1A-, alpha1B-, and alpha1D-adrenoceptors for prazosin, silodosin, and BMY 7378 did not significantly change under different assay conditions and in different tissues. The present study reveals that the pharmacological profiles of native alpha 1B-adrenoceptors for ketanserin is strongly influenced by the assay conditions and suggest that antagonist affinity is not necessarily constant.


Scientific Reports | 2016

STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α

Shota Yamauchi; Kenji Takeuchi; Kazuyasu Chihara; Chisato Honjoh; Yuji Kato; Hatsumi Yoshiki; Hak Hotta; Kiyonao Sada

Interferon-α (IFN-α) and IFN-λ are structurally distinct cytokines that bind to different receptors, but induce expression of similar sets of genes through Janus kinase (JAK)-signal transducers and activators of transcription (STAT) pathways. The difference between IFN-α and IFN-λ signaling remains poorly understood. Here, using the CRISPR/Cas9 system, we examine the role of STAT1 and STAT2 in the inhibition of hepatitis C virus (HCV) replication by IFN-α and IFN-λ. Treatment with IFN-α increases expression of IFN-stimulated genes (ISGs) such as double-stranded RNA-activated protein kinase (PKR) and decreases viral RNA and protein levels in HCV-infected Huh-7.5 human hepatoma cells. These responses are only partially attenuated by knockout of STAT1 but are abolished by knockout of STAT2. In contrast, the inhibition of HCV replication by IFN-λ is abolished by knockout of STAT1 or STAT2. Microarray analysis reveals that IFN-α but not IFN-λ can induce expression of the majority of ISGs in STAT1 knockout cells. These findings suggest that IFN-α can inhibit HCV replication through a STAT2-dependent but STAT1-independent pathway, whereas IFN-λ induces ISG expression and inhibits HCV replication exclusively through a STAT1- and STAT2-dependent pathway.


British Journal of Pharmacology | 2009

Expression of distinct α1-adrenoceptor phenotypes in the iris of pigmented and albino rabbits

Ikunobu Muramatsu; Fumiko Suzuki; Atsushi Nishimune; Asm Anisuzzaman; Hatsumi Yoshiki; T.-H. Su; Chang Ck; Shigeru Morishima

Background and purpose:  The expression of multiple pharmacological phenotypes including α1L‐adrenoceptor has recently been reported for α1‐adrenoceptors. The purpose of the present study was to identify α1‐adrenoceptor phenotypes in the irises of pigmented and albino rabbits.

Collaboration


Dive into the Hatsumi Yoshiki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Junsuke Uwada

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matomo Nishio

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Takanobu Taniguchi

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Takayoshi Masuoka

Kanazawa Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge